Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
Members of Congress who traded BCRX
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 5
- Filings
- 5
- Members
- 2
- Buys / sells
- 4 / 1
- Estimated volume
- $40.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.Democrat · House · CA | 2 | 2 / 0 | $16.0K | Jul 10, 2026 | Sep 4, 2026 |
| Josh GottheimerDemocrat · House · NJ | 3 | 2 / 1 | $24.0K | Oct 16, 2023 | Nov 11, 2023 |
Trades
Every reported trade in Biocryst Pharmaceuticals Inc, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Josh GottheimerDemocrat · House · NJ | BCRXBioCryst Pharmaceuticals, Inc. | Buy | Joint | Aug 11, 2022 | Sep 16, 2022 | 36 days | $1K-$15K | Filing |
| Josh GottheimerDemocrat · House · NJ | BCRXBioCryst Pharmaceuticals, Inc. | Sell | Joint | Sep 15, 2023 | Oct 15, 2023 | 30 days | $1K-$15K | Filing |
| Josh GottheimerDemocrat · House · NJ | BCRXBioCryst Pharmaceuticals, Inc. | Buy | Joint | Oct 16, 2023 | Nov 11, 2023 | 26 days | $1K-$15K | Filing |
| Gilbert Ray Cisneros, Jr.Democrat · House · CA | BCRXBioCryst Pharmaceuticals, Inc. - Common Stock | Buy | Self | Nov 13, 2025 | Dec 15, 2025 | 32 days | $1K-$15K | Filing |
| Gilbert Ray Cisneros, Jr.Democrat · House · CA | BCRXBioCryst Pharmaceuticals, Inc. - Common Stock | Buy | Self | Jul 10, 2026 | Sep 4, 2026 | 56 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.